July 2016

diabetic peripheral neuropathy

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial

VM BioPharma, the United States division of ViroMed Co., Ltd. in Seoul, Korea, announced the first patient was dosed in the recently initiated Phase 3 clinical study evaluating VM202, a proprietary DNA-based biopharmaceutical, in patients with painful diabetic peripheral neuropathy (DPN). This is the first pivotal gene therapy trial specifically targeting the most common cause …

Underlying Cause of Diabetic Peripheral Neuropathy Targeted in Gene Therapy Trial Read More »

chemo-induced peripheral neuropathy

Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker

Genetic Bio Marker may Predict Chemo-Induced Peripheral Neuropathy Side Effects Associated with Prostate Cancer Treatment New study finds genetic alterations in the VAC14 gene are associated with an increased risk of chemo-induced peripheral neuropathy in prostate cancer patients. Taxanes are a group of drugs commonly used to treat cancers of the breast, lung, ovary, or prostate, …

Chemo-Induced Peripheral Neuropathy may be Predicted by Genetic Bio Marker Read More »

Small Nerve Fibers Defy Neuropathy Conventions

Peripheral neuropathy research study suggests even prediabetes could cause nerve damage. Peripheral neuropathy research results of a small study of people with tingling pain in their hands and feet have added to evidence that so-called prediabetes is more damaging to motor nerves than once believed. The report on the study was published online in JAMA …

Small Nerve Fibers Defy Neuropathy Conventions Read More »